The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19

The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19

Background The coronavirus disease 2019 (COVID-19) pandemic has led to a disruptive increase in the number of intensive care unit (ICU) admissions with acute respiratory distress syndrome (ARDS). ARDS is a severe, life-threatening medical condition characterized by widespread inflammation and vascul...

Full description

Bibliographic Details
Main Authors: Atmowihardjo, L, Schippers, JR, Bartelink, IH, Bet, PM, van Rein, N, Purdy, K, Cavalla, D, Comberiati, V, McElroy, A, Snape, SD, Bogaard, HJ, Heunks, L, Juffermans, N, Schultz, M, Tuinman, PR, Bos, LDJ, Aman, J
Format: Journal article
Language:English
Published: BioMed Central 2022

Similar Items

Similar Items